Current study identifies that malignant cells in SCLC have inter‐patient and intra‐tumor heterogeneity, high expression of genes such as FZD8 in WNT pathway is associated with drug resistance, and SCLC harbors a unique immunosuppressive tumor microenvironment. Here, FZD8 is linked to small cell lung carcinoma.